← Leaderboards
Harshabad Singh
Dana-Farber Cancer Inst
$865,695
Attributed
$865,695
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $288.6K · FY2023–25$500K$375K$250K$125K$0
'23
'24
'25
Funding mix
By agency
NIH$865,695 · 1
By mechanism
K08$865,695 · 1
Top collaborators
No co-investigators on record.
Most similar at Dana-Farber Cancer Inst
Same institution · by research overlap
- Michael P. Verzi$9,649,868
- Jeffrey A Meyerhardt$15,207,814
- Tracy T Batchelor$27,819,477
- Kimmie Ng$5,327,974
- Ana Babic$747,324
Others in their field
Other Rising Stars on “Adjuvant Chemotherapy”
- Kathryn Marie Jones · Baylor College Of Medicine$3,103,804
- Amy Fowler · University Of Wisconsin-Madison$3,008,001
- Alice Chia- Chi Wei · Sloan-Kettering Inst Can Research$2,617,533
- Nadine Norton · Mayo Clinic Jacksonville$2,431,858
- Moustafa Gabr · Weill Medical Coll Of Cornell Univ$2,101,095
- Nduka Mgbechinyere Amankulor · University Of Pennsylvania$2,082,285
Research focus
Adjuvant ChemotherapyAdoptionAwardAdmixtureBiobankBiological Specimen BanksBiomarker SelectionBiopsyBasal CellCa-19-9 AntigenCancer BiologyCancer DiagnosisCareerCdkn2a GeneCell FractionCellsChemoresistanceChemotherapyChemotherapy-Oncologic ProcedureBloodClinical TrialsCohortDana-Farber Cancer InstituteDiagnosis
Grant awards (3)
Improving response prediction to neoadjuvant therapy in pancreatic cancer$288,565
K08 · FY2025 · CA · contact PI
Improving response prediction to neoadjuvant therapy in pancreatic cancer$288,565
K08 · FY2024 · CA · contact PI
Improving response prediction to neoadjuvant therapy in pancreatic cancer$288,565
K08 · FY2023 · CA · contact PI